Stock Track | Thermo Fisher Scientific Plummets 5.04% in Pre-Market as 2026 Profit Guidance Trails Estimates

Stock Track01-29

Thermo Fisher Scientific's stock plummeted 5.04% during Thursday's pre-market session, despite the company reporting better-than-expected fourth-quarter results.

The sharp decline followed the company's release of its 2026 financial outlook, which showed a profit forecast midpoint that fell short of analysts' expectations. While Thermo Fisher beat Q4 estimates with adjusted EPS of $6.57 versus the $6.45 estimate and revenue of $12.22 billion versus the $11.95 billion estimate, investors focused on the disappointing forward guidance.

The company expects 2026 adjusted earnings per share in the range of $24.22 to $24.80, with the midpoint of $24.51 coming in below the analysts' average estimate of $24.61. This guidance overshadowed the positive Q4 performance and triggered the significant pre-market sell-off.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment